Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma, Kaposi × Sirolimus × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Myelodysplastic Syndromes 13 Lymphoma, Non-Hodgkin 13 Leukemia, Myeloid, Acute 13 Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Mantle-Cell 12 Hodgkin Disease 12 Multiple Myeloma 10 Lymphoma 10 Leukemia 10 Sarcoma 9 Lymphoma, Large B-Cell, Diffuse 9 Graft vs Host Disease 9 Burkitt Lymphoma 9 Waldenstrom Macroglobulinemia 8 Myeloproliferative Disorders 8 Lymphoma, Follicular 8 Lymphoma, B-Cell, Marginal Zone 8 Tuberous Sclerosis 6 Primary Myelofibrosis 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lymphoma, Large-Cell, Immunoblastic 6 Leukemia, Myelomonocytic, Chronic 6 Congenital Abnormalities 6 Breast Neoplasms 6 Lymphoma, Large-Cell, Anaplastic 5 Lymphangioleiomyomatosis 5 Leukemia, Myeloid, Chronic-Phase 5 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 5 Leukemia, Myeloid, Accelerated Phase 5

Interventions

Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 Valganciclovir 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 tocilizumab 1 pomalidomide 1 pembrolizumab 1 liposomal doxorubicin 1 emvododstat 1 efineptakin alfa 1 Zidovudine 1 Sunitinib 1 Polymerase Chain Reaction 1 Nivolumab 1 Nelfinavir 1 Maraviroc 1 Lenalidomide 1 Ipilimumab 1 Immunohistochemistry 1 HhAntag691 1 Gene Expression Profiling 1 Etoposide 1 Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 CTLA-4 Antigen 1 Antiretroviral Therapy, Highly Active 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡